Sort by
Refine Your Search
-
Listed
-
Category
-
Field
-
of Oslo (UiO), Norway. We are seeking a candidate interested in debridement and the management of infected dental implants. This PhD position is part of the European Doctoral Network “SHIELD” (Strategies
-
8 Sep 2025 Job Information Organisation/Company University of Oslo Research Field Medical sciences » Cancer research Researcher Profile Established Researcher (R3) Positions Research Support
-
) /Institute of clinical dentistry , Faculty of Dentistry is offering a PhD opportunity on the investigation of serotonin receptor-mediated effects in 3D spheroid models. This interdisciplinary project will
-
debridement and the management of infected dental implants. This PhD position is part of the European Doctoral Network “SHIELD” (Strategies for Healing Implant-associated infections and Enhancing Longevity in
-
17 Sep 2025 Job Information Organisation/Company University of Oslo Research Field Other Researcher Profile First Stage Researcher (R1) Positions PhD Positions Country Norway Application Deadline 7
-
positions as PhD Research Fellow (SKO 1017) are available in the research project PROBONO . The project is funded by the European Research Council. The two research fellows will work together
-
Experimental Particle Physics is available at the Department of Physics, University of Oslo. The position is externally funded lasting throughout 2027. The vacancy will be filled as soon as possible. Project
-
position Position as researcher available at the Department of Physics, University of Oslo. The position is for a period of 2 years. Starting date as soon as possible, but no later than 01.11.2025. Place of
-
description Two positions as PhD Research Fellow (SKO 1017) are available in the research project PROBONO . The project is funded by the European Research Council. The two research fellows will work together
-
vesicles from NK cells Apply for this job See advertisement About the position A full-time phd position (SKO 1017) is available for 3 years in the “Innate Lymphocyte Group” led by professor Marit